$G

Kalra Balkrishan sold $368K of G

Kalra Balkrishan (President and CEO) sold 10,000 shares of Genpact LTD (G) at $36.79 ($0.37M total) on 2026-09-14.

Original reporting
SEC EDGAR · Kalra Balkrishan
Published Sep 16, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$G
Neutral
medium confidence
Mentioned
$G
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GNeutralLow
01

Why it matters

The disclosed sale is modest relative to insider holdings and unlikely to move the stock significantly.

02

Market read

Provides fresh insider transaction data for Genpact, useful for short‑term monitoring.

03

What to watch

Potential tax planning or diversification motives.

Relevance 4/10Novelty 4/10Timing: filed Sep 16 2026

Background

Form 4 filings disclose insider transactions; investors monitor for material signals.

Company-level read

Ticker impact

$GNeutralMedium confidence
Context

President and CEO Kalra Balkrishan sold 10,000 shares for $367,900 on Sep 14, 2026.

Expected impact

Potential short-term downward pressure, likely limited.

Evidence & confidence

Sale represents ~0.2% of post‑transaction holdings; market may view as routine.

Market effects

Minimal impact on business services sector.

No significant regional effect.

Limited to investors tracking Genpact.

Counterpoint

Sale could be unrelated to outlook; may present buying opportunity.

Key entities

  • Kalra Balkrishan

    President and CEO of Genpact

  • Genpact Ltd

    Global professional services firm (ticker G)

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GMed

Genpact’s ED NOC Rejection Quashed: Karnataka HC Remands Matter for Fresh Decision on USD 100 Million GIFT City Investment

The Karnataka High Court overturned the Enforcement Directorate's rejection of Genpact's application for a No-Objection Certificate (NOC) for a $100 million investment in GIFT City, stating that ongoing investigations alone do not justify refusal. The court also vacated interim protection against the ED's seizure of Genpact's Gurgaon property. The case involves a 2015 restructuring of Genpact's Indian operations and alleged FEMA violations.

MedAI 8/10

Karnataka High Court upholds ED seizure order against Genpact

The Karnataka High Court upheld an Enforcement Directorate (ED) seizure order against Genpact India under FEMA, while quashing the ED's refusal to grant a no-objection certificate (NOC) for $100 million overseas remittance. The court found the refusal lacked adequate reasons and ordered a fresh decision within 10 days. The ED had accused Genpact of siphoning foreign exchange, but the court did not rule on the merits of the case.

$GMedAI 8/10

Karnataka HC upholds Genpact office seizure in ₹7,800-cr case

The Karnataka High Court upheld the seizure of Genpact India's Gurugram office by the Enforcement Directorate in a ₹7,800-crore money-routing case. The court also directed authorities to reconsider Genpact's $100-million investment proposal in GIFT City. The case involves transactions with Morgan Stanley and Genpact entities.

$GMed

Genpact Q2 Earnings Call Highlights

Genpact (NYSE:G) said it expects more than $1 billion in agentic total contract value in 2026, about 5x 2025. Management reported 3% net revenue growth and 300 bps gross-margin expansion from clients shifting to agentic delivery. Q2 gross margin rose to 36.5%, adjusted operating income was $234M, and adjusted EPS was $1.00. Genpact reaffirmed 2026 revenue growth of at least 7% and guided Q3 revenue to $1.369B-$1.382B.